IGC Reports Financial Results for the Quarter Ended June 30, 2022 August 8, 2022August 8, 2022 by Alejandro
IGC Reports Financial Results for Fiscal Year Ended March 31, 2022 June 23, 2022June 23, 2022 by Alejandro
IGC Acquires Exclusive Rights for a Potential Alzheimer’sDrug Development Candidate June 21, 2022June 21, 2022 by Alejandro
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders June 9, 2022June 9, 2022 by Alejandro
India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits April 18, 2022April 18, 2022 by Alejandro
India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors March 23, 2022May 16, 2022 by Alejandro
IGC Reports Financial Results for the December 31, 2021 Quarter February 11, 2022February 11, 2022 by Alejandro
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients December 2, 2021December 2, 2021 by Alejandro
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability September 8, 2021September 8, 2021 by Alejandro
IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC July 22, 2021 by Alejandro
